EU approves Novartis' bone drug for use in men (Reuters, 30 September 2008)

01 Oct 2008


The Novartis osteoporosis drug, Aclasta, has been approved by the European Commission for use in men who are at an increased risk of bone fractures.

Full article


Share this story